Tumor-infiltrating lymphocytes in the immunotherapy era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-infiltrating lymphocytes in the immunotherapy era

Published:2020-11-02 Issue:4 Volume:18 Page:842-859
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Paijens Sterre T.,Vledder Annegé,de Bruyn Marco,Nijman Hans W.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41423-020-00565-9.pdf

Reference242 articles.

1. Zloza, A. & Al-Harthi, L. Multiple populations of T lymphocytes are distinguished by the level of CD4 and CD8 coexpression and require individual consideration. J. Leukoc. Biol. 79, 4–6 (2006).

2. Parrot, T. et al. Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma. Sci Rep. 10, 5900 (2020).

3. Menard, L. C. et al. Renal cell carcinoma (RCC) tumors display large expansion of double positive (DP) CD4+CD8+ T cells with expression of exhaustion markers. Front Immunol. 9, 2728 (2018).

4. Bohner, P. et al. Double positive CD4+CD8+ T cells are enriched in urological cancers and favor T helper-2 polarization. Front Immunol. 10, 622 (2019).

5. Desfrançois, J. et al. Double positive CD4CD8 αβ T cells: a new tumor-reactive population in human melanomas. PLoS One. 5, e8437 (2010).

Cited by 511 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamical properties of a stochastic tumor–immune model with comprehensive pulsed therapy;Communications in Nonlinear Science and Numerical Simulation;2025-01

2. Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity;International Immunopharmacology;2024-12

3. Melittin-incorporated nanomedicines for enhanced cancer immunotherapy;Journal of Controlled Release;2024-11

4. Advancements in tumor-infiltrating lymphocytes: Historical insights, contemporary milestones, and future directions in oncology therapy;Critical Reviews in Oncology/Hematology;2024-10

5. DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer;Translational Research;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3